Literature DB >> 17913700

Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing.

Tatyana Novoyatleva1, Bettina Heinrich, Yesheng Tang, Natalya Benderska, Matthew E R Butchbach, Christian L Lorson, Monique A Lorson, Claudia Ben-Dov, Pascale Fehlbaum, Laurent Bracco, Arthur H M Burghes, Mathieu Bollen, Stefan Stamm.   

Abstract

Alternative splicing emerges as one of the most important mechanisms to generate transcript diversity. It is regulated by the formation of protein complexes on pre-mRNA. We demonstrate that protein phosphatase 1 (PP1) binds to the splicing factor transformer2-beta1 (tra2-beta1) via a phylogenetically conserved RVDF sequence located on the RNA recognition motif (RRM) of tra2-beta1. PP1 binds directly to tra2-beta1 and dephosphorylates it, which regulates the interaction between tra2-beta1 and other proteins. Eight other proteins, including SF2/ASF and SRp30c, contain an evolutionary conserved PP1 docking motif in the beta-4 strand of their RRMs indicating that binding to PP1 is a new function of some RRMs. Reducing PP1 activity promotes usage of numerous alternative exons, demonstrating a role of PP1 activity in splice site selection. PP1 inhibition promotes inclusion of the survival of motoneuron 2 exon 7 in a mouse model expressing the human gene. This suggests that reducing PP1 activity could be a new therapeutic principle to treat spinal muscular atrophy and other diseases caused by missplicing events. Our data indicate that the binding of PP1 to evolutionary conserved motifs in several RRMs is the link between known signal transduction pathways regulating PP1 activity and pre-mRNA processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17913700     DOI: 10.1093/hmg/ddm284

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  54 in total

1.  Plasmodium falciparum inhibitor-3 homolog increases protein phosphatase type 1 activity and is essential for parasitic survival.

Authors:  Aline Fréville; Isabelle Landrieu; M Adelaida García-Gimeno; Jérôme Vicogne; Muriel Montbarbon; Benjamin Bertin; Alexis Verger; Hadidjatou Kalamou; Pascual Sanz; Elisabeth Werkmeister; Christine Pierrot; Jamal Khalife
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

2.  Role of SFRS13A in low-density lipoprotein receptor splicing.

Authors:  I-Fang Ling; Steven Estus
Journal:  Hum Mutat       Date:  2010-06       Impact factor: 4.878

3.  The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x.

Authors:  Lulzim Shkreta; Laetitia Michelle; Johanne Toutant; Michel L Tremblay; Benoit Chabot
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

4.  Synthesis of a norcantharidin-tethered guanosine: Protein phosphatase-1 inhibitors that change alternative splicing.

Authors:  Stefan Kwiatkowski; Vitaliy M Sviripa; Zhaiyi Zhang; Alison E Wendlandt; Claudia Höbartner; David S Watt; Stefan Stamm
Journal:  Bioorg Med Chem Lett       Date:  2015-12-18       Impact factor: 2.823

Review 5.  Spinal muscular atrophy: an update on therapeutic progress.

Authors:  Joonbae Seo; Matthew D Howell; Natalia N Singh; Ravindra N Singh
Journal:  Biochim Biophys Acta       Date:  2013-08-27

Review 6.  Control of alternative pre-mRNA splicing by Ca(++) signals.

Authors:  Jiuyong Xie
Journal:  Biochim Biophys Acta       Date:  2008-01-17

7.  Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-β1.

Authors:  Antoine Cléry; Sandrine Jayne; Natalya Benderska; Cyril Dominguez; Stefan Stamm; Frédéric H-T Allain
Journal:  Nat Struct Mol Biol       Date:  2011-03-13       Impact factor: 15.369

8.  Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript.

Authors:  Dairong Feng; Yi Cheng; Yan Meng; Liping Zou; Shangzhi Huang; Jiuyong Xie
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

Review 9.  Alternative splicing and disease.

Authors:  Jamal Tazi; Nadia Bakkour; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2008-10-17

10.  Control of alternative splicing by signal-dependent degradation of splicing-regulatory proteins.

Authors:  Rebeccah J Katzenberger; Matthew S Marengo; David A Wassarman
Journal:  J Biol Chem       Date:  2009-02-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.